Exact Mass: 284.1624
Exact Mass Matches: 284.1624
Found 198 metabolites which its exact mass value is equals to given mass value 284.1624,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Tropisetron
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants > A04AA - Serotonin (5ht3) antagonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent Same as: D02130 Tropisetron (SDZ-ICS-930 free base) is a selective 5-HT3 receptor antagonist and α7-nicotinic receptor agonist with an IC50 of 70.1 ± 0.9 nM for 5-HT3 receptor. IC50 value: 70.1 ± 0.9 nM [1] Target: 5-HT3 receptor in vitro: Tropisetron specifically inhibited both IL-2 gene transcription and IL-2 synthesis in stimulated T cells. tropisetron inhibited both the binding to DNA and the transcriptional activity of NFAT and AP-1. We also observed that tropisetron is a potent inhibitor of PMA plus ionomycin-induced NF-(kappa)B activation but in contrast TNF(alpha)-mediated NF-(kappa)B activation was not affected by this antagonist [2]. Tropisetron prevents the phosphorylation and thus activation of the p38 MAPK, which is involved in post-transcriptional regulation of various cytokines [3]. in vivo: Two different doses of tropisetron (5 and 10 mg/kg) or vehicle were administered intraperitoneally 30 min before pMCAO. Neurological deficit scores, mortality rate and infarct volume were determined 24 h after permanent focal cerebral ischemia [4].
tropicamide
S - Sensory organs > S01 - Ophthalmologicals > S01F - Mydriatics and cycloplegics > S01FA - Anticholinergics C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics
Alpha-dihydroartemisinin
Artenimol is an active metabolite of artesunate, with anti-malarial activity, and potential insulin sensitivity-improving, anti-inflammatory, immunomodulating and antineoplastic activities. Upon administration of artenimol and the hydrolysis of its active endoperoxide bridge moiety by liberated heme in parasite-infected red blood cells (RBCs), reactive oxygen species (ROS) and carbon-centered radicals form, which damage and kill parasitic organisms. Artenimol may also increase insulin sensitivity and improve insulin resistance. In addition, artenimol induces the 26S proteasome-mediated degradation of the androgen receptor (AR), thereby lowering AR expression, which may prevent androgen-responsive cellular proliferation. It also reduces luteinizing hormone LH) and testosterone levels, and may improve polycystic ovary syndrome (PCOS). In addition, artenimol may modulate the immune system and may inhibit tumor cell proliferation through various apoptotic and non-apoptotic pathways. Alpha-dihydroartemisinin is a metabolite of artemisinin. Artemisinin, also known as Qinghaosu, and its derivatives are a group of drugs that possess the most rapid action of all current drugs against Plasmodium falciparum malaria. Treatments containing an artemisinin derivative (artemisinin-combination therapies, ACTs) are now standard treatment worldwide for P. falciparum malaria. The starting compound artemisinin is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. (Wikipedia) P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BE - Artemisinin and derivatives, plain D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D009676 - Noxae > D016877 - Oxidants > D010545 - Peroxides Dihydroartemisinin is a potent anti-malaria agent. Dihydroartemisinin is a potent anti-malaria agent.
Tropicamide
Tropicamide is only found in individuals that have used or taken this drug. It is one of the muscarinic antagonists with pharmacologic action similar to atropine and used mainly as an ophthalmic parasympatholytic or mydriatic. [PubChem]Tropicamide binds to and blocks the receptors in the muscles of the eye (muscarinic receptor M4). Tropicamide acts by blocking the responses of the iris sphincter muscle to the iris and ciliary muscles to cholinergic stimulation, producing dilation of the pupil and paralysis of the ciliary muscle. S - Sensory organs > S01 - Ophthalmologicals > S01F - Mydriatics and cycloplegics > S01FA - Anticholinergics C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics
6,7-Dihydro-4-(hydroxymethyl)-2-(p-hydroxyphenethyl)-7-methyl-5H-2-pyrindinium
Minor alkaloid from the roots of Valeriana officinalis (valerian). 6,7-Dihydro-4-(hydroxymethyl)-2-(p-hydroxyphenethyl)-7-methyl-5H-2-pyrindinium is found in tea, fats and oils, and herbs and spices. 6,7-Dihydro-4-(hydroxymethyl)-2-(p-hydroxyphenethyl)-7-methyl-5H-2-pyrindinium is found in fats and oils. Minor alkaloid from the roots of Valeriana officinalis (valerian).
Dihydroartemisinin (DHA)
Dihydroartemisinin (DHA) is a metabolite of artemether. Artemether is an antimalarial for the treatment of multi-drug resistant strains of falciparum malaria. It is combined with Lumefantrine and sold by Novartis under the brand names Riamet and Co-Artem. (Wikipedia)
Dihydroartemisinin
4-(8-Amino-1,2,3,4-tetrahydro-2-methyl-4-isoquinolinyl)-2-methoxyphenol
5-(8-Amino-1,2,3,4-tetrahydro-2-methyl-4-isoquinolinyl)-2-methoxyphenol
8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 1H-indole-3-carboxylate
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Tropisetron (SDZ-ICS-930 free base) is a selective 5-HT3 receptor antagonist and α7-nicotinic receptor agonist with an IC50 of 70.1 ± 0.9 nM for 5-HT3 receptor. IC50 value: 70.1 ± 0.9 nM [1] Target: 5-HT3 receptor in vitro: Tropisetron specifically inhibited both IL-2 gene transcription and IL-2 synthesis in stimulated T cells. tropisetron inhibited both the binding to DNA and the transcriptional activity of NFAT and AP-1. We also observed that tropisetron is a potent inhibitor of PMA plus ionomycin-induced NF-(kappa)B activation but in contrast TNF(alpha)-mediated NF-(kappa)B activation was not affected by this antagonist [2]. Tropisetron prevents the phosphorylation and thus activation of the p38 MAPK, which is involved in post-transcriptional regulation of various cytokines [3]. in vivo: Two different doses of tropisetron (5 and 10 mg/kg) or vehicle were administered intraperitoneally 30 min before pMCAO. Neurological deficit scores, mortality rate and infarct volume were determined 24 h after permanent focal cerebral ischemia [4].
2-Hydroxy-4-[(1R)-1-hydroxy-8-methyl-6-oxononyl]-3-methyl-2H-furan-5-one
[3S-(3alpha,3aalpha,5aalpha,6alpha,8beta,9beta,9aalpha,9bbeta)]-Decahydro-6,8,9-trihydroxy-3,5a,9-trimethylnaphtho[1,2-b]furan-2(3H)-one
(4E,6E)-2-(hydroxymethyl)-3-(3-methoxy-3-oxopropyl)deca-4,6-dienoic acid
(1alpha,3beta,4Z,6alpha,10alpha,12betaH)-form-1,3,10-Trihydroxy-4-germacren-12,6-olide
N-[2-(4-methoxyphenyl)ethyl]-2-(methylamino)benzamide
(1R,2S,4E,7S,9R,11R)-2,7,9-trihydroxy-3,3,7,11-tetramethyl-12-oxabicyclo[9.1.0]dodec-4-en-6-one|mitissimol G
(1alpha,4beta,5alpha,6alpha,11betaH)-form-1,4,5-Trihydroxy-12,6-eudesmanolide|1alpha,4beta,5alpha-trihydroxyeudesman-6beta,11betaH-12,6-olide
(1R,4S,5S,5aR,6R,8aS,9R)-octahydro-5,9-dihydroxy-6-hydroxymethyl-5a-methyl-9-(1-methylethyl)-1,4-methano-2H-cyclopent[d]oxepin-2-one|dendronobilin B
(1R,4R,5S,5aR,6R,8aS,9S)-octahydro-5-hydroxy-6-hydroxymethyl-9-[(1RS)-2-hydroxy-1-methylethyl]-5a-methyl-1,4-methano-2H-cyclopent[d]oxepin-2-one|(1R,4R,5S,5aR,6R,8aS,9S)-octahydro-5-hydroxy-6-hydroxymethyl-9-[(1SR)-2-hydroxy-1-methylethyl]-5a-methyl-1,4-methano-2H-cyclopent[d]oxepin-2-one|dendronobilin D|dendronobilin E
(1R,2S,3R,4S,5R,6S,9R)-2,3,11,12-tetrahydroxypicrotoxan-12(15)-lactone|findlayanin
4-hydroxy-3-methoxy-11-methyldecahydro-1H-benzoxecine-1,12-dione
(6S,7E,9S)-6,9-dihydroxy-10-(2-hydroxyethoxy)-4,7-megastigmadien-3-one|holostymegastigmadienone
(4E,6E)-2-(hydroxymethyl)-3-(3-methoxy-3-oxopropyl)deca-4,6-dienoic acid
[5-hydroxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylbutanoate
(4E,6E)-2-(hydroxymethyl)-3-(3-methoxy-3-oxopropyl)deca-4,6-dienoic acid
C15H24O5_1-Naphthalenecarboxylic acid, 1,4,4a,5,6,7,8,8a-octahydro-1,4-dihydroxy-2-(hydroxymethyl)-5,5,8a-trimethyl
[5-hydroxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylbutanoate
artenimol
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BE - Artemisinin and derivatives, plain D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D009676 - Noxae > D016877 - Oxidants > D010545 - Peroxides
Dihydroartemisinin
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BE - Artemisinin and derivatives, plain D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D009676 - Noxae > D016877 - Oxidants > D010545 - Peroxides C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent Origin: Plant; SubCategory_DNP: Sesquiterpenoids Dihydroartemisinin is a potent anti-malaria agent. Dihydroartemisinin is a potent anti-malaria agent.
(4E,6E)-2-(hydroxymethyl)-3-(3-methoxy-3-oxopropyl)deca-4,6-dienoic acid [IIN-based on: CCMSLIB00000847701]
(4E,6E)-2-(hydroxymethyl)-3-(3-methoxy-3-oxopropyl)deca-4,6-dienoic acid [IIN-based: Match]
[5-hydroxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylbutanoate_major
6,7-Dihydro-4-(hydroxymethyl)-2-(p-hydroxyphenethyl)-7-methyl-5H-2-pyrindinium
4-[(2-Isopropyl-5-methylphenoxy)methyl]phenylboronic acid
3-[(2-Isopropyl-5-methylphenoxy)methyl]phenylboronic acid
1H-Indole-1-carboxylicacid,3-(1-cyano-1-methylethyl)-,1,1-dimethylethylester
ETHYL5-BENZYL-4,5,6,7-TETRAHYDRO-1H-PYRROLO[3,2-C]PYRIDINE-2-CARBOXYLATE
1-BENZYL-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRAZOLE
1-Methyl-3-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
1-(2-AMINO-PHENYL)-AZETIDINE-3-CARBOXYLICACIDMETHYLESTER
Pyrrolidine, 1-[(7-ethyl-3-formyl-1H-indol-1-yl)acetyl]- (9CI)
Azepino[4,5-b]indole-5-carboxylic acid,1,2,3,6-tetrahydro-1,1-dimethyl-,ethylester
ethyl 2-(1-benzylpiperidin-4-ylidene)-2-cyanoacetate
[2-[(5-methyl-2-propan-2-ylphenoxy)methyl]phenyl]boronic acid
2-[4-(1-METHYL-1-PHENYLETHYL)PHENOXY]ACETOHYDRAZIDE
5-Methyl-1-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
Trimecaine HCl
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents
1-benzyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazole
4-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)aniline
1-Methyl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazole
3-{4-[(2-Isopropoxyethoxy)methyl]phenoxy}-1,2-propanediol
4-Methoxynaphthalen-1-ylboronic acid pinacol ester
3-(6-Amino-3-methylpyridin-2-yl)benzoic acid tert-butyl ester
1-[2-(4-METHYL-1-PIPERIDINYL)-2-OXOETHYL]-1H-INDOLE-3-CARBALDEHYDE
3-methyl-2-(1-methylpiperidin-4-yl)-6-pyridin-4-ylpyrimidin-4-one
3-Methoxy-6-[4-(3-methylphenyl)-1-piperazinyl]pyridazine
5-amino-4-(1H-benzimidazol-2-yl)-1-pentyl-2H-pyrrol-3-one
5,5-Diethyl-2-hydrazinyl-1,6-dihydrobenzo[h]quinazolin-4-one
Dihydroqinghaosu
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BE - Artemisinin and derivatives, plain D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D009676 - Noxae > D016877 - Oxidants > D010545 - Peroxides Dihydroartemisinin is a potent anti-malaria agent. Dihydroartemisinin is a potent anti-malaria agent.
N-(4-methoxyphenyl)-N-[2-(6-methylpyridin-2-yl)ethyl]acetamide
2-Hydroxy-4-[(1R)-1-hydroxy-8-methyl-6-oxononyl]-3-methyl-2H-furan-5-one
3H-indole-3-carboxylic acid [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] ester
Merulin B, (rel)-
D009676 - Noxae > D016877 - Oxidants > D010545 - Peroxides A natural product found in Endophytic fungi.
1,4-dihydroxy-2-(hydroxymethyl)-5,5,8a-trimethyl-4a,6,7,8-tetrahydro-4H-naphthalene-1-carboxylic acid
(1S,6S,9S,10S)-10-hydroxy-10-(hydroxymethyl)-2,2,6-trimethyl-7,8-dioxatricyclo[7.3.1.01,6]tridecan-5-one
(2R,4S)-6,6-dimethoxy-1-phenylmethoxyhexane-2,4-diol
(2S,3S,4R)-1-[cyclopentyl(oxo)methyl]-4-(hydroxymethyl)-3-phenyl-2-azetidinecarbonitrile
(2R,3S,4S)-1-[cyclopentyl(oxo)methyl]-4-(hydroxymethyl)-3-phenyl-2-azetidinecarbonitrile
(2R,3R,4R)-1-(cyclopentanecarbonyl)-4-(hydroxymethyl)-3-phenylazetidine-2-carbonitrile
(2R,3S,4R)-1-[cyclopentyl(oxo)methyl]-4-(hydroxymethyl)-3-phenyl-2-azetidinecarbonitrile
(2S,3S,4S)-1-[cyclopentyl(oxo)methyl]-4-(hydroxymethyl)-3-phenyl-2-azetidinecarbonitrile
(2S,3R,4R)-1-[cyclopentyl(oxo)methyl]-4-(hydroxymethyl)-3-phenyl-2-azetidinecarbonitrile
(2R,3R,4S)-1-[cyclopentyl(oxo)methyl]-4-(hydroxymethyl)-3-phenyl-2-azetidinecarbonitrile
(2S,3R,4S)-1-[cyclopentyl(oxo)methyl]-4-(hydroxymethyl)-3-phenyl-2-azetidinecarbonitrile
1-Hydroxy-7,8-dimethoxy-3,3,4,4-tetramethyl-10-oxatricyclo(5.2.1.0(2,5))decan-6-one
1-[2,3-dihydroxy-6-(hydroxymethyl)-2-methyl-3,5,6,7,8,8a-hexahydro-1h-naphthalen-1-yl]-3-hydroxypropan-1-one
(1r,6r)-8,9-dihydroxy-9-(hydroxymethyl)-2,2,6-trimethyl-7-oxatricyclo[6.3.1.0¹,⁶]dodecan-5-one
(2r,2as,3s,4ar,7r,7ar,7br)-2,7a-bis(hydroxymethyl)-2,4a-dimethyl-1h,3h,4h,7h,7bh-cyclobuta[e]indene-2a,3,7-triol
2-[(2r,3s,6s,8s,8ar)-3,6-dihydroxy-8,8a-dimethyl-2,3,5,6,7,8-hexahydro-1h-naphthalen-2-yl]-3-hydroxypropanoic acid
2,7a-bis(hydroxymethyl)-2,4a-dimethyl-1h,3h,4h,7h,7bh-cyclobuta[e]indene-2a,3,7-triol
4-[(4e)-6-hydroperoxy-3-hydroxy-6-methylhept-4-en-2-yl]cyclohex-1-ene-1-carboxylic acid
10-hydroxy-10-(hydroxymethyl)-2,2,6-trimethyl-7,8-dioxatricyclo[7.3.1.0¹,⁶]tridecan-5-one
4a-hydroperoxy-7-hydroxy-6-(2-hydroxypropan-2-yl)-4,8a-dimethyl-5,6,7,8-tetrahydro-1h-naphthalen-2-one
(1r,2s,6r,7s,8r,11s,12s,13r)-1,4,4-trimethyl-10-oxatetracyclo[6.4.1.0²,⁶.0¹¹,¹³]tridecane-7,8,11,12-tetrol
5-hydroxy-3-[(1r)-1-hydroxy-8-methyl-6-oxononyl]-4-methyl-5h-furan-2-one
(3r,3as,6r,6as,9s,9as,9br)-6,6a,9-trihydroxy-3,6,9a-trimethyl-octahydroazuleno[4,5-b]furan-2-one
2-hydroxyaeginetic acid
{"Ingredient_id": "HBIN005776","Ingredient_name": "2-hydroxyaeginetic acid","Alias": "NA","Ingredient_formula": "C15H24O5","Ingredient_Smile": "NA","Ingredient_weight": "284.352","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8611","PubChem_id": "NA","DrugBank_id": "NA"}
aeginetic acid; 2α-hydroxy
{"Ingredient_id": "HBIN014749","Ingredient_name": "aeginetic acid; 2\u03b1-hydroxy","Alias": "NA","Ingredient_formula": "C15H24O5","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7138","PubChem_id": "NA","DrugBank_id": "NA"}
bisaborosaol d
{"Ingredient_id": "HBIN018589","Ingredient_name": "bisaborosaol d","Alias": "NA","Ingredient_formula": "C15H24O5","Ingredient_Smile": "CC(C1CCC(=CC1)C(=O)O)C(C=CC(C)(C)OO)O","Ingredient_weight": "284.35 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14483","TCMID_id": "2422","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101608764","DrugBank_id": "NA"}
